Epidemiological prospective studies have shown that increased chromosomal aberrations
(CAs) in peripheral blood lymphocytes may predict cancer risk. Here, we report CAs in newly …

Background: The majority of human cancers arise from cells unable to maintain genomic
stability. Recent prospective studies indicated that enhanced chromosomal aberrations …

The frequency of cells with structural chromosomal aberrations (CAs) in peripheral blood
lymphocytes is the first genotoxicity biomarker that has shown an association with cancer …

Chromosomal aberrations (CAs), sister chromatid exchanges (SCEs), and micronuclei (MN)
in peripheral blood lymphocytes have for decades been used as cytogenetic biomarkers to …

To investigate the existence of an association between the frequency of chromosome
aberrations (CA) in non-target tissues and cancer risk, a historical cohort study was carried …

Mechanistic evidence linking chromosomal aberration (CA) to early stages of cancer has
been recently supported by the results of epidemiological studies that associated CA …

An increased risk of cancer in healthy individuals with high levels of chromosomal
aberrations (CAs) in peripheral blood lymphocytes has been described in recent …

Nonspecific chromosomal aberrations (CAs) are found in about 1% of lymphocytes drawn
from healthy individuals. They include chromosome‐type aberrations (CSAs), which are …

Previous studies have suggested that the frequency of chromosomal aberrations (CAs), but
not of sister chromatid exchanges (SCEs), predicts cancer risk. We have further examined …

A high level of chromosomal aberrations in peripheral blood lymphocytes may be an early
marker of cancer risk, but data on risk of specific cancers and types of chromosomal …